Real world data (RWD) are no substitute for a well-run randomized clinical trial, but they can help developers, regulators and clinicians better understand patients and how a drug candidate stands to impact patient care. In this report, Clarivate examines how drug companies are using RWD sources such as claims, EHR/EMR and registry data to better understand patients, conditions, and how drug candidates stand to impact patient care.
In this report, Clarivate examines how drug developers are using RWD to shape, supplement, enhance and accelerate their clinical trials, including:
Download the full report to learn more.